1 AI Stock To Avoid In 2024
The story and hype around artificial intelligence drove a whole wave of technology stocks higher in 2023. Some of the gains were well-deserved and others, like Broadcom, might have mushroomed to unsustainable levels for 2024.
We took a peek at the financials to see if the current valuation matches with the price and, candidly, what we discovered surprised us. » Read more about: 1 AI Stock To Avoid In 2024 »
Read More
ARKK: 40% Annually For Next 5 Years?
What’s an ETF?
» Read more about: ARKK: 40% Annually For Next 5 Years? »
Read More
Market Commentary: 1 Marine Stock On Sale
Buying a boat manufacturer ranks right up there as one of the most treacherous investments when interest rates are elevated, at least on the surface.
But then there’s Marine Products Corporation that trades with a price-to-earnings ratio of just 7x. Not only is the PE ratio attractive but the earnings have been growing steadily quarter over quarter and operating income looks very attractive for the past three years too.
» Read more about: Market Commentary: 1 Marine Stock On Sale »
Read MoreThe Ivy
60.2% Upside In This Forgotten Favorite
When we wrote about Apple’s bullish opportunity frankly we weren’t expecting it to be the only stock that held up in the market but the graphic below highlights just how awful Friday’s market was and how nothing escaped the onslaught but the Cupertino giant.
But what other stock could be on the verge of rising after a period of sustained underperformance?
» Read more about: 60.2% Upside In This Forgotten Favorite »
Read MoreThe Spotlight
Is This Healthcare Stock The NEXT BIG THING?
Doximity is a cloud-based platform that helps medical professionals connect and collaborate with their colleagues. It has been compared to LinkedIn for doctors by allowing them to search for new job opportunities, keep up with the latest medical research, and communicate with other physicians in a more efficient way.
The company has an estimated 80% of US doctors on the platform in addition to a large number of top pharmaceutical companies and hospitals in the US,
» Read more about: Is This Healthcare Stock The NEXT BIG THING? »
Read MoreThe Daily
Wall Street issues its most bullish S&P outlook yet for 2025
Wall Street’s high-water mark for the S&P 500 (^GSPC) projects a nearly 17% increase from current levels at the end of 2025.
On Monday, Deutsche Bank chief global strategist Binky Chadha issued a year-end target of 7,000 for the S&P 500, matching Yardeni Research’s call as the most bullish among strategists tracked by Yahoo Finance.
» Read more about: Wall Street issues its most bullish S&P outlook yet for 2025 »